SEC Company Response from WINDTREE THERAPEUTICS (WINT) — Feb 10, 2014
WINDTREE THERAPEUTICS INC /DE/ (WINT, WINTW) (CIK 0000946486)
Date: Feb. 10, 2014 · CIK: 0000946486 · Accession: 0001140361-14-005614
AI Filing Summary & Sentiment
File numbers found in text: 333-193490
Letter
Division of Corporation Finance United States Securities and Exchange Commission Re: Discovery Laboratories, Inc. Registration Statement on Form S-3 Filed January 22, 2014 (File No. 333-193490)
Dear Ms. De Rosa:
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, Discovery Laboratories, Inc., a Delaware corporation (the “Company”), hereby requests that the effectiveness of the Company’s Registration Statement on Form S-3, File No. 333-193490, be accelerated to 4:30 p.m. (New York time), February 12, 2014, or as soon thereafter as is practicable.
Very truly yours,
DISCOVERY LABORATORIES, INC.
Show Raw Text
CORRESP 1 filename1.htm DISCOVERY LABORATORIES, INC. 2600 Kelly Rd, Suite 100 Warrington, PA 18976 P - 215.488.9443 F - 215.488.9557 www.discoverylabs.com February 10, 2014 Christina M. De Rosa Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Discovery Laboratories, Inc. Registration Statement on Form S-3 Filed January 22, 2014 (File No. 333-193490) Dear Ms. De Rosa: Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, Discovery Laboratories, Inc., a Delaware corporation (the “Company”), hereby requests that the effectiveness of the Company’s Registration Statement on Form S-3, File No. 333-193490, be accelerated to 4:30 p.m. (New York time), February 12, 2014, or as soon thereafter as is practicable. Very truly yours, DISCOVERY LABORATORIES, INC. /s/ Mary B. Templeton Mary B. Templeton Senior Vice President, General Counsel and Corporate Secretary Cc: Ira L. Kotel